LAURUSLAB presents compelling buy-side technical opportunity holding above pivot ₹952.13 support (S1 ₹929.06/S2 ₹913.23) near oversold STOCHRSI levels signaling capitulation exhaustion after recent correction, with bullish MACD(12.07-17.56) crossover confirming momentum restoration despite short-term resistance at R1 ₹967.96. Strong Buy technical indicators (9/11 oscillators including RSI 62-69.9 Buy, ADX 54+ trend strength) validate accumulation phase creating favorable risk-reward setup targeting R2 ₹991.03/R3 ₹1006.86 breakout, supported by higher lows formation above S3 ₹890.16 volume zone. Attractive long entry with tight stops below S2 ₹913.23 for optimal upside capture in this pharma formulations leader amid US generics tailwinds.
Warning-
Disclaimer– Registration granted by SEBI, membership of a SEBI recognized supervisory body (BSE) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Disclosure– Investments in securities market are subject to market risks, read all the related documents carefully before investing.